Tradestie Institutional Equity Comparison Engine
PTH vs BBC โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
BBC Overall Edge
BBC Captures Institutional Edge (2โ0 Pillars ยท 0โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Virtus LifeSci Biotech Clinical Trials ETF (BBC) driven by superior Momentum & Technical, Options & Structure. Fundamentally, PTH trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus BBC at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, PTH sits in UNCLASSIFIED (100th %ile IV; Dealer Gamma Walls on Pro) against BBC sits in UNCLASSIFIED (2nd %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
PTH N/M vs BBC N/M Fwd P/E
Growth & Margin Winner
Tie
Op Margin N/A vs N/A ยท YoY N/A vs N/A
Momentum & Technical Winner
BBC
1Y +17.5% vs +29.8% ยท 52W Pos 54% vs 38%
Options & Structure Winner
BBC
UNCLASSIFIED (100th %ile IV) vs UNCLASSIFIED (2nd %ile IV)
PTH
NASDAQ
Invesco Exchange-Traded Fund Trust Invesco Dorsey Wright Healthcare Momentum ETF
Institutional Equity
$55.90
-2.46% 1D
Market Cap
N/A
1M Return
+0.01%
1Y Return
+17.52%
Forward P/E
N/M
Unified AI Score
49.2 / 100
HOLD
Tech 43.0
Fund 50.0
Flow 50.0
Mom 60.0
BBC
NYSE Arca
Virtus LifeSci Biotech Clinical Trials ETF
Institutional Equity
$40.85
-3.94% 1D
Market Cap
N/A
1M Return
+4.42%
1Y Return
+29.84%
Forward P/E
N/M
Unified AI Score
43.9 / 100
HOLD
Tech 46.0
Fund 52.0
Flow 50.0
Mom 60.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
PTH +17.52%
BBC +29.84%
Spread: +12.32 pp (BBC Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
PTH TTM Op. Margin: N/A
BBC TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on PTH vs BBC. Trailing 12-month operating profitability (PTH N/A vs BBC N/A) and valuation multiples (PTH N/M vs BBC N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | PTH | BBC | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | N/A | N/A | Larger Scale | Tie |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | N/A | N/A | Higher Growth | Tie |
| Operating Margin (TTM) Profitability | N/A | N/A | Higher Margin | Tie |
| Net Profit Margin Profitability | N/A | N/A | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | N/A | N/A | Higher ROE | Tie |
| 52-Week Range Position Momentum | 54% ($46โ$64) | 38% ($31โ$56) | Stronger Trend | PTH |
| Beta / 30D Volatility Risk Regime | 1.22ฮฒ ยท 41% Vol | 1.45ฮฒ ยท 50% Vol | Lower Realized Risk | PTH |
| Unified Institutional Score Composite Signal | 49.2 / 100 (HOLD) | 43.9 / 100 (HOLD) | Higher Composite | PTH |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full PTH vs BBC Buy Guide
PTH
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
100th %ile
IV Regime
Extreme (>80th %ile)
BBC
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
2nd %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither PTH nor BBC registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.